Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access will find a wealth of contextualized life science insight ready to be viewed in the FENIX Marketplace.
Welcome to FENIX Syndicated Services. If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact us.
$599
Posted in: Other Mar 10 | 2020Thoughts on FDA's New Draft Guidance for T2DM TrialsPurchase Blast$599
Posted in: SGLT2i Mar 09 | 2020New dapa HF study (DICTATE-AHF) in T2DM patients with acute decompensated heart failurePurchase Blast$599
Posted in: Other Mar 04 | 2020Voluntis Deprioritizes Diabetes in Favor of OncologyPurchase Blast$599
Posted in: Insulin Delivery Mar 04 | 2020Thoughts on Tandem Basal IQ iAGC DesignationPurchase Blast$599
Posted in: Glucose Monitoring Mar 03 | 2020Nemaura Launches sugarBEAT CGM App on Google PlayPurchase Blast$599
Posted in: GLP-1RA Feb 28 | 2020New Ozempic Switching Study from other GLP-1RA (SUSTAIN SWITCH)Purchase Blast$599
Posted in: Basal Insulin Feb 27 | 2020Mylan Q4 '19 Earnings Update; Bs-glargine Briefly DiscussedPurchase Blast$599
Posted in: Glucose Monitoring Feb 26 | 2020FDA Approves Senseonics Extension Study for 365-Day CGMPurchase Blast$599
Posted in: Glucose Monitoring, Other Feb 25 | 2020New Nemaura H2H CGM Study; Welldoc partners with Redox to integrate BlueStar with EHRsPurchase Blast$599
Posted in: Bolus Insulin, GLP-1RA, GLP-1RA + Basal, SGLT2i Feb 25 | 2020CREDENCE CHMP Opinion This Week? DAPA-HF Filed with EMA; CHMP Agenda February 24-27Purchase Blast$599
Posted in: Insulin Delivery Feb 24 | 2020Tandem t:slim Smartphone Control in H2 '20; Tandem Q4 '19 Earnings UpdatePurchase Blast$599
Posted in: Insulin Delivery Feb 24 | 2020New Companion Medical 510(k) Clearance for Expanded Dose Calculator ModesPurchase Blast$599
Posted in: GLP-1RA Feb 22 | 2020Lilly REWIND Approved for Primary and Secondary PreventionPurchase Blast